Brisbane under the microscope

Hundreds of doctors and scientists from all over the world met in Brisbane for the inaugural Global Controversies and Advances in Skin Cancer Conference (GC-SC).

The aim of the meeting was to create an international forum for top-level discussion on the liveliest current debates surrounding skin cancer and its various treatments.

Differing approaches to preventing, diagnosing, and tackling the widespread disease came under the microscope at the Brisbane Convention and Exhibition Centre (BCEC).

World leaders unite

When Brisbane hosts the G20 Summit of world leaders in November this year the city and its world-class convention and exhibition centre (BCEC) will be in the global spotlight.
The G20 (Group of Twenty) is the world’s most high-profile forum for global economic cooperation and collaboration, representing 85 per cent of economic output.
The event is expected to attract 4,000 delegates and 3,000 journalists and will drive international conference business for Brisbane and the BCEC well into the future.
The 2014 G-20 Australia summit takes place 15 -16 November, 2014.

 More than 400 delegates took part in the four-day event, which was the result of work by the BCEC Convention Advocates Partnership, a group of influential Australian scientists, academics and business leaders whose aim is to raise the meetings profile of Brisbane.

Renowned scientist Professor Ian Frazer, developer of the world’s first cancer vaccine and BCEC Convention Advocate, joined a stellar list of local skin cancer specialists on the organising committee, chaired by Professor Richard Lewandowski.
Lewandowski said debate on the controversies, management and prevention of skin cancer would ‘rage for decades’.
“I thought the issue of controversies and problems in the skin cancer space were being tackled by people who probably didn’t quite have the breadth and depth of knowledge that we have here in Queensland as the skin cancer capital of the world,” he said.

Debate centred on a number of issues, including the need for a skin cancer vaccine, vitamin D recommendations, and advice about sun exposure, screening and early detection.

Steering Committee Member and PCO, Ashley Gordon from Carillon Conference Management, said having a ‘world class’ scientific programme was extremely important for a first-time event: “The fact the GC-SC covered so many separate but also related fields developed into a powerful proposition for potential delegates.”

He added: “The fact that an inaugural conference lacks history and the prestige of established events does present challenges, particularly with sponsorship and recruiting top level speakers. In the case of GC-SC these issues were only overcome by the generous support and contribution of key individuals and organisations and a strong belief in the overall objective.”

CEO of Cancer Council Queensland and Co-convenor of the conference, Professor Jeff Dunn, hailed the event a tremendous success. “The response from delegates was overwhelmingly positive and we now look forward to hosting the 2015 conference and continuing the momentum of global efforts to combat skin cancer,” he said.

Alison Gardiner
Manager International Convention Bidding, Brisbane Convention & Exhibition Centre
Tel:  +61 7 3308 3073